Scaleup programmes
Back to programmesProgramme
Amadeus Capital Partners [2022]
Finance and Risk Capital
Impact for scaleups
46
UK companies backed
48%
Follow-on investments
52%
Investments outside of London
42
Growth-stage investments
Amadeus Capital Partners is a global technology investor that invests in companies requiring early investment and growth capital with global potential. Founded by Anne Glover and Herman Hauser in 1997, Amadeus now has a team of over 40. One-third of the firm’s early stage investment team are women.
The firm follows three investment strategies: providing seed, start-up and scaleup capital for early stage companies with exceptional IP based in, or growing from the UK; primary and secondary investments in high-growth technology companies; and growth capital investments in tech-enabled consumer and business services in emerging markets. It is focused on AI & machine learning, online consumer services, cyber security, digital health and medical technology, digital media, enterprise SaaS, fintech, regtech and insurtech.
The firm has offices in London, Cambridge, Oxford, San Francisco and São Paulo. It is a partner with the British Business Bank on the Enterprise Capital Fund programme. Its latest £110m Amadeus V Technology Fund includes a cornerstone commitment by British Patient Capital.
Notable scaleups in their current portfolio include chip designers Graphcore, graphene company Paragraf [see the scaleup story with CEO Dr Simon Thomas], cell and gene therapy manufacturing platform OriBiotech, Nuclera and PolyAi.
In the period between January 2015 to June 2022, the average turnover of companies in its portfolio was £4.1m and the estimated average number of employees was 50.
Alongside investment Amadeus supports scaling businesses with technical insight, operational experience and access to a global network. They connect portfolio companies to additional support for innovation and growth including access to mentors and NEDs.
